The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.radonc.2019.07.018 | DOI Listing |
Publication Analysis
Top Keywords
single fraction
8
fraction urethra-sparing
8
prostate cancer
8
shot trial
8
urethra-sparing prostate
4
cancer sbrt
4
sbrt phase
4
phase shot
4
trial shot
4
trial phase
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!